Israeli companies shutting down Turkish operations
Israeli sanitaryware maker Hamat said it will shut down MCP, its ceramic sanitaryware unit in Izmir, citing difficulties marketing in Turkey and other markets. The move follows Israel’s broader reduction of direct ties with Turkish industry amid political tensions. Globes reports 2025 imports from Turkey fell to $924.1m from ~$2bn in 2024, while exports dropped to $10.9m from $598.6m.
How this was made
The 30-second read
Why it matters
Hamat’s decision is a concrete corporate action that reduces direct Turkey operations; the broader narrative suggests increasing difficulty for Israeli exporters and rising geopolitical risk for firms with Turkey assets.
Market read
Traders may reassess geopolitical exposure and potential impairment/exit risk for Israeli industrial and pharma firms with Turkey footprints, but only Hamat has a clearly new action in the text.
What to watch
The article provides no unit-level revenue/cost data for MCP, so the financial materiality to Hamat is uncertain; also, continued operations by other firms may mitigate sector-wide read-across.
Background
The article frames Hamat’s shutdown as part of Israel gradually disconnecting from Turkish industry amid Ankara’s strict anti-Israel trade policy and a May 2024 trade embargo.
Ticker impact
ICL (Israel Chemicals) operates a Rotem plant in Bandirma, producing calcium phosphate and industrial cleaning materials, including for Turkey.
No clear directional move from this article alone; risk remains but no new event beyond continued operations.
The text describes existing footprint rather than a new decision, contract, or disruption.
Teva includes the Turkish market in its international operations, with Turkish headquarters in Istanbul for drug marketing activities.
Likely minimal immediate trading signal without a fresh Turkey-specific disruption or guidance change.
The article is primarily about Israeli companies shutting down Turkey operations; Teva is mentioned as still active without new facts.
Market effects
Highlights geopolitical-driven de-risking from Turkey for Israeli industrials (sanitaryware/irrigation/chemicals) and potential supply-chain/logistics disruptions.
Suggests Turkish industrial recovery is occurring despite reduced Israeli trade flows, implying Israeli firms face demand/access constraints rather than Turkey-wide collapse.
Reinforces that Israel–Turkey political tensions can quickly translate into corporate footprint changes, affecting cross-border risk premia for multinational Israeli companies.
Counterpoint
Some Israeli firms (Netafim, ICL, Teva) remain in Turkey, implying the market can still be served via local production/marketing and third-country channels despite embargo rhetoric.
Key entities
- companyHamat
Israeli sanitaryware firm shutting down its Turkish subsidiary MCP in Izmir.
- subsidiaryMCP
Hamat’s Turkish subsidiary producing ceramic sanitaryware.
- companyNetafim
Israeli irrigation company continuing operations in Turkey via a local facility.
- companyICL
Israeli chemicals company operating the Rotem plant in Bandirma, Turkey.
- companyTeva
Israeli pharma company maintaining Turkish headquarters for drug marketing activities.
